{"id":"cacb369f-4774-4d7e-81d5-234b29d6b7ff","kind":"companies","code":"UB-C7494","name":"Huixian Pharmaceutical","nameBasis":"transliterated","summary":"Microfluidic in-vitro diagnostics and intelligent laboratory testing platform.","description":"","country":null,"category":null,"originalName":"汇先医药","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-08T00:00:00.000Z","englishUpdatedAt":"2026-10-15T20:20:54.788Z","reviewedAt":"2026-10-15T20:20:54.788Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"74bb0ca091479dde40de4a86e3f0c200e573afca7a54c2065c6d03a75da3a5ab","companyId":null,"foundedYear":null,"logoUrl":null,"originalText":"微流控体外诊断与智慧检验平台","sources":[],"related":[{"id":"95eafe62-570d-480f-8625-f0d502b56cb3","kind":"news","code":"95eafe62-570d-480f-8625-f0d502b56cb3","name":"Huixian Pharmaceutical completes strategic financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"汇先医药完成战略投资融资","eventDate":"2024-11-08T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-14T10:48:13.241Z","englishUpdatedAt":"2026-10-15T18:29:25.552Z","reviewedAt":"2026-10-15T18:29:25.552Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"83804b4c51ff89abfb9cd8bf6042ed647083c26a74b0990ccae49c3dbfbde213","companyId":"cacb369f-4774-4d7e-81d5-234b29d6b7ff","foundedYear":null,"logoUrl":null,"path":"/news/95eafe62-570d-480f-8625-f0d502b56cb3"},{"id":"093193f5-a5c2-4e15-bd85-7ffd71551b3f","kind":"institutions","code":"UB-I5571","name":"昆高新集团","nameBasis":"transliterated","summary":"Kungaoxin Group, a venture capital firm focused on technology investments.","description":"Kungaoxin Group, a venture capital firm focused on technology investments.","country":null,"category":null,"originalName":"昆高新集团","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:28:24.938Z","englishUpdatedAt":"2026-10-15T17:35:38.565Z","reviewedAt":"2026-10-15T17:35:38.565Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"034fc371cf159ed6f257fd01221cafb7916011762fac93333e3849e98b3ea625","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Kungaoxin Group","path":"/institutions/kungaoxin-group"}],"finance":{"funding":{"metric":"funding","count":1,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":1,"records":[{"id":"95eafe62-570d-480f-8625-f0d502b56cb3","date":"2024-11-08T00:00:00.000Z","round":"Strategic","amountText":"未披露","estimateUsd":null,"estimateLabel":"Undisclosed","estimateNote":null,"investors":"昆高新集团","institutions":[{"id":"093193f5-a5c2-4e15-bd85-7ffd71551b3f","kind":"institutions","code":"UB-I5571","name":"昆高新集团","nameBasis":"transliterated","summary":"Kungaoxin Group, a venture capital firm focused on technology investments.","description":"Kungaoxin Group, a venture capital firm focused on technology investments.","country":null,"category":null,"originalName":"昆高新集团","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:28:24.938Z","englishUpdatedAt":"2026-10-15T17:35:38.565Z","reviewedAt":"2026-10-15T17:35:38.565Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"034fc371cf159ed6f257fd01221cafb7916011762fac93333e3849e98b3ea625","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Kungaoxin Group","path":"/institutions/kungaoxin-group"}],"newsUrl":null,"evidence":{"headline":"Huixian Pharmaceutical completes strategic financing","brief":null,"basis":null,"newsPath":"/news/95eafe62-570d-480f-8625-f0d502b56cb3","sourceCount":0}}],"totalRaised":null},"valuation":{"metric":"valuation","count":1,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":1,"records":[{"id":"95eafe62-570d-480f-8625-f0d502b56cb3","date":"2024-11-08T00:00:00.000Z","round":"Strategic","amountText":null,"estimateUsd":null,"estimateLabel":null,"estimateNote":null,"investors":"昆高新集团","institutions":[{"id":"093193f5-a5c2-4e15-bd85-7ffd71551b3f","kind":"institutions","code":"UB-I5571","name":"昆高新集团","nameBasis":"transliterated","summary":"Kungaoxin Group, a venture capital firm focused on technology investments.","description":"Kungaoxin Group, a venture capital firm focused on technology investments.","country":null,"category":null,"originalName":"昆高新集团","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:28:24.938Z","englishUpdatedAt":"2026-10-15T17:35:38.565Z","reviewedAt":"2026-10-15T17:35:38.565Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"034fc371cf159ed6f257fd01221cafb7916011762fac93333e3849e98b3ea625","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Kungaoxin Group","path":"/institutions/kungaoxin-group"}],"newsUrl":null,"evidence":{"headline":"Huixian Pharmaceutical completes strategic financing","brief":null,"basis":null,"newsPath":"/news/95eafe62-570d-480f-8625-f0d502b56cb3","sourceCount":0}}]},"revenue":{"metric":"revenue","count":0,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":0,"records":[]}},"events":[{"id":"95eafe62-570d-480f-8625-f0d502b56cb3","kind":"funding","eventDate":"2024-11-08T00:00:00.000Z","revenueDate":null,"round":"战略投资","amountText":"未披露","valuationText":null,"revenueText":"","cumulativeFundingText":"","amountEstimateUsd":null,"valuationEstimateUsd":null,"revenueEstimateUsd":null,"cumulativeFundingEstimateUsd":null,"investors":"昆高新集团","newsUrl":null,"newsTypes":["融资"],"institutions":[{"id":"093193f5-a5c2-4e15-bd85-7ffd71551b3f","kind":"institutions","code":"UB-I5571","name":"昆高新集团","nameBasis":"transliterated","summary":"Kungaoxin Group, a venture capital firm focused on technology investments.","description":"Kungaoxin Group, a venture capital firm focused on technology investments.","country":null,"category":null,"originalName":"昆高新集团","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:28:24.938Z","englishUpdatedAt":"2026-10-15T17:35:38.565Z","reviewedAt":"2026-10-15T17:35:38.565Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"034fc371cf159ed6f257fd01221cafb7916011762fac93333e3849e98b3ea625","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Kungaoxin Group","path":"/institutions/kungaoxin-group"}],"roundName":"Strategic","amountLabel":"Undisclosed","valuationLabel":null,"revenueLabel":null,"cumulativeFundingLabel":null}],"team":[],"productsRelated":[],"investors":[{"id":"093193f5-a5c2-4e15-bd85-7ffd71551b3f","kind":"institutions","code":"UB-I5571","name":"昆高新集团","nameBasis":"transliterated","summary":"Kungaoxin Group, a venture capital firm focused on technology investments.","description":"Kungaoxin Group, a venture capital firm focused on technology investments.","country":null,"category":null,"originalName":"昆高新集团","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:28:24.938Z","englishUpdatedAt":"2026-10-15T17:35:38.565Z","reviewedAt":"2026-10-15T17:35:38.565Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"034fc371cf159ed6f257fd01221cafb7916011762fac93333e3849e98b3ea625","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Kungaoxin Group","path":"/institutions/kungaoxin-group"}],"path":"/companies/UB-C7494","structured":{"city":null,"country":null,"location":null,"role":null,"category":null,"company":null},"definition":"Huixian Pharmaceutical is a company.","summaryBasis":"translated","thin":false,"canonical":"https://uniquebase.ai/companies/UB-C7494"}